CGON
CGON
NASDAQ · Biotechnology

Cg Oncology Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$65.81
+1.97 (+3.09%)
As of Mar 25, 9:56 PM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 20 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -45.4% upside
Low Target $23.54
Average Target $35.94
High Target $41.91
Current Price $65.81
Current
$65.81
Target
$35.94
$23.54 $35.94 avg $41.91
Scenario Analysis
Bear Case
$23.54
-64.2%
Low target
Base Case
$35.94
-45.4%
Avg target
Bull Case
$41.91
+-36.3%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$57.88
13.7% from high
52-Week Low
$14.80
+344.7% from low
50-Day SMA
$47.74
+37.9% vs SMA
200-Day SMA
$36.07
+82.5% vs SMA
RSI (14)
57.5
Neutral
Target vs 52W High
$35.94
-37.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%